National Biomedical Research Centers
Funds specialised biomedical research centers built to replace animal testing with new human-based research models.
Whole-animal research is expensive, slow, and increasingly something funders expect a project to justify rather than default to. This notice funds centres built to give researchers a genuine alternative, at national scale.
National Biomedical Research Centers, or NBRCs, provide scientific expertise, advanced equipment, infrastructure and well-characterised research models to researchers nationall…
Specialised biomedical research centers (P50) providing shared scientific expertise, advanced equipment, infrastructure and well-characterised research models to researchers nationally, with an explicit mandate to develop innovative human-based New Approach Methodologies (NAMs) that reduce, refine and replace whole-animal use. Open competition, including at centres with existing nonhuman primate colonies. Clinical trials are allowed only as human-based NAMs.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →Advanced Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the enhancement of a cancer informatics tool that has cleared prototyping, shows real promise, and has not yet been widely adopted.
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All
🇺🇸NIH · United States
Funds a single hub that coordinates data, evaluation and operations for a consortium of community-based oral health research projects.
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03)
🇺🇸NIH · United States
Funds one small self-contained project for a scholar already inside the Clinical and Translational Science Award network, on the way to a first full award.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
NIH · United States
Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data
NIH · United States
Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.
Sustained Support for Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the running costs and continued relevance of a cancer informatics tool that researchers already depend on.
Similar grants
Browse the directory →
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Frontier Health and Medical Research
🇦🇺DoHDA · Australia
Funds breakthrough and frontier health and medical research with potential to transform health outcomes.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.
EIC Accelerator Challenge: Biotech for Regenerating Agricultural Soils
🇪🇺EIC · European Union
Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.